Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03552133 · ClinicalTrials.gov registry record · NA
Variable Dead Space Rebreathing Device to Treat Sleep Apnea
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT03552133 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 13 participants.
The verdict
NCT03552133, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to determine the feasibility of using a novel treatment for sleep apnea in which the patient's own exhaled CO2 is tightly controlled and used in a rebreathe system to reduce sleep disordered breathing.
Interventions
- DEVICE Smart CO2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2016-08 |
| Est. Completion | 2019-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03552133
The ClinicalTrials.gov registry entry for NCT03552133 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Smart CO2 is the first listed.
NCT03552133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03552133 about?
NCT03552133 is a clinical study titled "Variable Dead Space Rebreathing Device to Treat Sleep Apnea". The purpose of this pilot study is to determine the feasibility of using a novel treatment for sleep apnea in which the patient's own exhaled CO2 is tightly controlled and used in a rebreathe system to reduce sleep disordered breathing.
What is the current status of trial NCT03552133?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2016-08. Estimated completion is 2019-10-01.
What interventions are being tested in trial NCT03552133?
The interventions under investigation include: Smart CO2 (DEVICE).
Who is sponsoring clinical trial NCT03552133?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.